Table 3.
Synchronous primary tumor and secondary peritoneal samples.
| Trial | Type of TR Analysis | Pts with Adequate Block | Pts with Primary Tumor Samples | Pts. with Synchronous Primary and Secondary Lesions | Pts. with Secondary Lesion Only |
|---|---|---|---|---|---|
| MITO2 | IHC | 239 | 230 | 52 | 8 |
| Molecular * | 214 | 180 | 42 | 34 | |
| MITO7 | IHC | 158 | 127 | 49 | 31 |
| Molecular | 136 | 108 | 41 | 28 | |
| MITO16A | IHC | 358 | 252 | 58 | 106 |
| Molecular | 290 | 223 | 41 | 67 | |
| MITO16B | IHC | 313 | 180 | 31 | 133 |
| Molecular | 256 | 165 | 26 | 91 |
TR: translational research; Pts: patients: IHC: immunohistochemestry. * miRNA and/or gene expression profiles.